Growth Metrics

Emergent BioSolutions (EBS) Long-Term Debt Repayments (2017 - 2021)

Emergent BioSolutions' Long-Term Debt Repayments history spans 6 years, with the latest figure at $10.6 million for Q1 2021.

  • For Q1 2021, Long-Term Debt Repayments changed N/A year-over-year to $10.6 million; the TTM value through Dec 2021 reached $10.6 million, changed N/A, while the annual FY2021 figure was $10.6 million, N/A changed from the prior year.
  • Long-Term Debt Repayments reached $10.6 million in Q1 2021 per EBS's latest filing, up from -$20.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $20.0 million in Q1 2017 to a low of -$20.0 million in Q4 2017.